How big is Atea Pharmaceuticals, Inc.?

Jun 22 2025 05:49 PM IST
share
Share Via
As of Jun 18, Atea Pharmaceuticals, Inc. has a market capitalization of 274.71 million and reported net sales of 0.00 million with a net profit of -139.48 million over the latest four quarters. The balance sheet as of Dec'24 shows shareholder's funds of 438.87 million and total assets of 464.67 million.
As of Jun 18, Atea Pharmaceuticals, Inc. has a market capitalization of 274.71 million, categorizing it as a Micro Cap company.

As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a net profit of -139.48 million during the same period.

As of Dec'24, the balance sheet shows shareholder's funds of 438.87 million and total assets of 464.67 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Atea Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 08:40 AM IST
share
Share Via
What does Atea Pharmaceuticals, Inc. do?
Jun 22 2025 06:25 PM IST
share
Share Via